Cargando…

Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients

The aim of this study is to explore a novel classification and investigate the clinical significance of hepatocellular carcinoma (HCC) cells. We analyzed integrated single-cell RNA sequencing and bulk RNA-seq data obtained from HCC samples. Cell trajectory analysis divided HCC cells into three subgr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jun, Wang, Haoyun, Lv, Xin, Mao, Lipeng, Huang, Junyan, Hao, Tao, Li, Junliang, Qi, Shuo, Chen, Guodong, Jiang, Haiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426728/ https://www.ncbi.nlm.nih.gov/pubmed/37589009 http://dx.doi.org/10.1515/biol-2022-0656

Ejemplares similares

Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
por: Xiang, Renshen, et al.
Publicado: (2021)

Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis
por: Qin, Yuling, et al.
Publicado: (2022)

A Differentiation-Related Gene Prognostic Index Contributes to Prognosis and Immunotherapy Evaluation in Patients with Hepatocellular Carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories
por: Yin, Ji, et al.
Publicado: (2022)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Circular RNA Signature in Hepatocellular Carcinoma
por: Qiu, Lipeng, et al.
Publicado: (2019)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients
por: Wang, Zihao, et al.
Publicado: (2020)

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma
por: Cheng, Wei, et al.
Publicado: (2021)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy
por: Qu, Jialin, et al.
Publicado: (2023)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma
por: Ning, Yumei, et al.
Publicado: (2023)

Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms
por: Qiu, Lipeng, et al.
Publicado: (2017)

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
por: Jiang, Yu, et al.
Publicado: (2019)

Estimation of Bounded and Unbounded Trajectories in Diffusion MRI
por: Ning, Lipeng, et al.
Publicado: (2016)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma
por: Zhang, Yu, et al.
Publicado: (2022)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
por: Pang, Mu, et al.
Publicado: (2023)

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022)

Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients
por: Shen, Xiaogang, et al.
Publicado: (2023)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
por: Chen, Lin, et al.
Publicado: (2021)

Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma
por: Wu, Qing, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Yang, Yongyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ffq5qrehma4ffophde847krln